Hyperbaric oxygen therapy (HBOT) has emerged as a promising adjunctive treatment to manage complications of diabetes, particularly those associated with poor blood circulation. Diabetes often leads to microvascular dysfunction, impaired angiogenesis, and chronic inflammation, which together reduce oxygen delivery to tissues, delay wound healing, and increase the risk of infections and neuropathy